Cleared Abbreviated

K061137 - ADVIA IMS CPSA CONTROL

K061137 is an FDA 510(k) clearance for ADVIA IMS CPSA CONTROL, manufactured by Bayer Healthcare, LLC. The device is a Class 1 Immunology device with product code JJY cleared through the Abbreviated 510(k) pathway after a 73-day FDA review.

K061137 · Bayer Healthcare, LLC · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2006
Decision
73d
Days
Class 1
Risk

K061137 is an FDA 510(k) clearance for the ADVIA IMS CPSA CONTROL. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Bayer Healthcare, LLC (Tarrytown, US). The FDA issued a Cleared decision on July 6, 2006 after a review of 73 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1660 - the FDA immunology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Bayer Healthcare, LLC devices

FDA 510(k) Submission Details - K061137

510(k) Number K061137 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 24, 2006
Decision Date July 06, 2006
Days to Decision 73 days
Submission Type Abbreviated
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 104d · This submission: 73d
Pathway characteristics
Standards-based clearance path.

JJY Device Classification - Class 1, General Controls

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 546
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K061137.
MISSION TRINITY B
K062674 · Diamond Diagnostics, Inc. · Dec 2006
CLINIQA LIQUID QC CARDIAC MARKER CONTROL SP, LEVELS 1,2, &3
K062916 · Cliniqa Corporation · Oct 2006
AUDIT MICROCV IMMUNOASSAY LINEARITY SET
K062668 · Aalto Scientific, Ltd. · Oct 2006
CARDIOIMMUNE XL CARDIAC MARKER CONTROL
K061196 · Microgenics Corp. · May 2006
CLINIQA LIQUID QC LIPID CONTROL LEVELS 1 & 2
K061182 · Cliniqa Corporation · May 2006
MISSION COMPLETE
K060206 · Diamond Diagnostics, Inc. · Mar 2006